David L. Reich, MD

Chief Clinical Officer, Mount Sinai Health System. President, Mount Sinai Hospital, Professor of Anesthesiology, cardiac anesthesiologist. Opinions are my own.

[Mount Sinai Tisch Cancer Center @TischCancer]

Marina Kremyanskaya, MD, PhD, has been named Chief Quality Officer at the Mount Sinai Tisch Cancer Center. She will advance clinical quality and operational excellence across cancer care sites throughout the Mount Sinai Health System.
@MKremyanskaya @IcahnMountSinai

[Friedman Brain Institute @SinaiBrain]

✨After emerging from an international field of semifinalists announced in May 2025, Mount Sinai’s NYC-Vita Clinical Trial Team was selected as a Milestone 2 Award recipient, advancing to the @xprize Healthspan Finals. Huge Congratulations🎉Learn More 👉 https://t.co/rCbL8CPmhF

[Eric J. Nestler, MD, PhD @EricJNestler]

Check out this latest collection of updates on Mount Sinai's continuing leadership across our research, educational, and clinical missions. @IcahnMountSinai https://t.co/SrpXg6gMlV

[Friedman Brain Institute @SinaiBrain]

Researchers Brittany Hemmer, @JM_Castell, et al. ID TIMP2 as a potential molecular link between youthful systemic factors & healthier brain immune function, providing new insight into how age-related changes in the brain may be modified. PRESS RELEASE👉 https://t.co/Ny5ZXfot8Y

[Mount Sinai Department of Medicine @DOMSinaiNYC]

Congratulations to Sarah Stanley, MBBCh, PhD, Professor of Medicine (Endocrinology, Diabetes and Bone Disease) at the Icahn School of Medicine at Mount Sinai, on being named an inaugural recipient of the 2026 Robin Chemers Neustein Scholar Award. #WeFindAWat

[Mount Sinai Tisch Cancer Center @TischCancer]

https://t.co/3FgKy60gEp
“We are honored to continue this journey with XPRIZE Healthspan and collaborate with innovators worldwide who are working to transform healthy aging,” says @MiriamMerad.
@SinaiImmunol @IcahnMountSinai

[Friedman Brain Institute @SinaiBrain]

On Tues, Sept. 29th, 10am, the #BrainBodySeminarSeries is excited to welcome @Columbia's Dr. Lori Zeltser. Join host Dr. Sarah Stanley when Dr. Zeltser presents "Regulation of Glucose Homeostasis by the Peripheral Nervous System". Register Here 👉 https://t.co/2p8ydIk6ce

[Icahn School of Medicine at Mount Sinai @IcahnMountSinai]

At a ballet studio just blocks from the Icahn School of Medicine at Mount Sinai, something remarkable is happening. Three medical students, all with a shared love of ballet, are teaching ballet to children with autism, and the results go far beyond the dance floor. Improved balance, coordination, confidence, and connection are just some of what this free, 12-week program is delivering to families who've long had limited access to recreational activities adapted to their children's needs.

Read their story: https://t.co/HpR7EVUnlw

#MedicalStudents

[Eric J. Nestler, MD, PhD @EricJNestler]

We are delighted and proud that Dr. Judy Cho of Mount Sinai will serve as the next Director of @NHGRI. An inspiring choice to lead such an important and impactful enterprise for our nation. Congratulations to Dr. Cho and to @NIH. @IcahnMountSinai https://t.co/bpiSGYwKON

[Friedman Brain Institute @SinaiBrain]

🎉Please join us in congratulating @chriskellnerMD, Director of the Cerebrovascular Center @MountSinaiNeuro who has been elected Chair of the joint @AANSNeuro/@CNS_Update Cerebrovascular Section. Congratulations Dr. Kellner💫Press Release | Learn More👉 https://t.co/LZrHTcB1vd

[Mount Sinai Department of Medicine @DOMSinaiNYC]

In a recent @healio publication, Manasi Agrawal, MD, MS of @IcahnMountSinai discusses new research finding that exposure to PFAs during pregnancy and early life is associated with increased intestinal inflammation during childhood. Read more: https://t.co/wbXOCCgcD7

[Miriam Merad, MD, PhD @MiriamMerad]

I enjoyed contributing to this @nytimes piece on the role of macrophages in driving inflammation, how chronic inflammation contributes to many major human diseases, and the growing potential of targeting inflammation to prevent and treat disease. @SinaiImmunol #Inflammation

[Mount Sinai Dermatology @MSHSDerm]

A new expert consensus report, led by Dr. Saakshi Khattri, Dr. Mark Lebwohl & Dr. Jeffrey Weinberg, found IL-17 and IL-23 inhibitors demonstrate strong efficacy and safety across multiple PsA manifestations. Details:📖 https://t.co/0JqZ8wwHc6 #PsA @EmmaGuttman @IcahnMountSinai

[Icahn School of Medicine at Mount Sinai @IcahnMountSinai]

Researchers at Mount Sinai have identified immune system changes that can be detected up to 10 years before inflammatory bowel disease (IBD) develops, offering new insight into how the disease begins.

Published in @Gut_BMJ, the study is one of the most comprehensive investigations to date of the preclinical phase of IBD. Using antibody profiling technology, researchers analyzed nearly 2,000 blood samples collected over about a decade from people who later developed Crohn's disease or ulcerative colitis.

They identified unique antibody signatures against viruses and bacteria — particularly Epstein-Barr virus and bacterial flagellins — that were present years before diagnosis, suggesting that abnormal immune activity begins long before the disease becomes clinically apparent.

The findings could eventually help identify people at increased risk for IBD, particularly relatives of patients with the disease, and guide future prevention strategies.

Read more: https://t.co/Eq41dRpPz0

@DOMSinaiNYC @MountSinaiGI @JeanFredericCo1
#IBD #CrohnsDisease #UlcerativeColitis #Research

[Grad School at Icahn Mount Sinai @GradSchoolSinai]

Orientation is underway at @GradSchoolSinai! After an exciting Day 1 yesterday, our newest graduate students are continuing to build connections, explore campus resources, and prepare for the journey ahead. We can't wait to see all that you'll accomplish. 🔬

#GradSchool

[Eric J. Nestler, MD, PhD @EricJNestler]

See this new publication by Susan Yim, Freddyson Martinez-Rivera, and others in @molpsychiatry that describes the role played by the transcription factor E2F3a in nucleus accumbens in the lasting actions of cocaine. @SinaiBrain https://t.co/0Ckzkor8f2

[Mount Sinai Tisch Cancer Center @TischCancer]

Congratulations to Nina Bhardwaj, MD, PhD, @BhardwajLab, @CancerResearch CLIP investigator.
Dr. Bhardwaj's project: Defining vaccine-induced immunity against mutated Calreticulin in myeloproliferative neoplasms
https://t.co/y2fT1ES5yE
@IcahnMountSinai

[Icahn School of Medicine at Mount Sinai @IcahnMountSinai]

We are proud to share that a team led by Kuan-lin Huang, PhD, has been named a winner of the $1 million Alzheimer’s Insights AI Prize from the Alzheimer’s Disease Data Initiative (AD Data Initiative) for the development of Biomni-AD, an advanced AI-powered “co-scientist” designed to dramatically reduce the time required to generate scientific insights from complex biomedical data.

“Receiving this prize validates that AI can contribute to Alzheimer’s research right now, not someday,” said Dr. Huang.

Learn more about the key capabilities and innovations of Biomni-AD: https://t.co/yAzzMkZq7e

@MountSinaiPsych @SinaiBrain @AlzData
#AlzheimersDisease #ArtificialIntelligence #Neuroscience

[Mount Sinai Tisch Cancer Center @TischCancer]

Congratulations to Brian Brown, PhD, @Brown_lab1, recipient of Technology Impact Award from @CancerResearch
https://t.co/V83gZfHAQC
@IcahnMountSinai

[Eric J. Nestler, MD, PhD @EricJNestler]

Please see my new essay in Curr Opin Neurobiol that outlines exciting new opportunities to directly study the human brain and fundamentally advance basic, translational, and clinical neuroscience. @SinaiBrain @IcahnMountSinai https://t.co/ZQusZaKvOB